IGF2BP1 and hepatocellular carcinoma: The fact that neither LIN28B-AS1 siRNA nor LIN28B-AS1 overexpression was effective in IGF2BP1-KO HCC cells indicates that LIN28B-AS1-mediated HCC cell progression requires binding to IGF2BP1.